Home › Therapeutic areas › Oncology › Ovarian Cancer
Ovarian Cancer (16 companies)
Companies with an active program in Ovarian Cancer.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ANIX | Anixa Biosciences | Oncology | 2 | Phase 1 | 3 |
| CGEN | Compugen | Oncology | 2 | Phase 3 | 7 |
| CBIO | Crescent Biopharma | Oncology | 1 | Phase 2 | 10 |
| EIKN | Eikon Therapeutics | Oncology | 2 | Phase 2 | 13 |
| GNLX | Genelux | Oncology | 1 | Phase 3 | 3 |
| IDYA | IDEAYA Biosciences | Oncology | 1 | NDA Submitted | 13 |
| IMTX | Immatics | Oncology | 1 | Phase 3 | 8 |
| IMCR | Immunocore | DermatologyInfectious Disease+2 | 1 | Approved | 11 |
| IMNM | Immunome | Oncology Rare | 1 | NDA Submitted | 9 |
| PMVP | PMV Pharmaceuticals | Oncology | 1 | Phase 2 | 7 |
| RXRX | Recursion Pharmaceuticals | Oncology | 1 | Phase 2 | 9 |
| SLS | SELLAS Life Sciences Group | Oncology | 1 | Phase 3 | 9 |
| VSTM | Verastem | Oncology | 1 | Approved | 5 |
| XNCR | Xencor | ImmunologyNeurology+1 Rare | 2 | Approved | 28 |
| ZNTL | Zentalis Pharmaceuticals | Oncology | 1 | Phase 3 | 1 |
| ZYME | Zymeworks | OncologyRespiratory | 2 | Approved | 11 |
No companies match.